B60.19 Other acanthamebic disease

Name of the Condition

• Other acanthamebic disease

Summary

Other acanthamebic disease refers to infections caused by free-living amoebae of the genus Acanthamoeba that do not fall into more specific categories (e.g., keratitis, meningoencephalitis). These infections can affect various body systems, including the skin, respiratory tract, or other organs, and require targeted diagnostic and therapeutic approaches. The condition is rare but can lead to significant morbidity, particularly in immunocompromised individuals.

Causes

The infection is caused by Acanthamoeba species, which are ubiquitous in environmental sources such as soil, water, and air. Transmission typically occurs through direct contact with contaminated water (e.g., swimming in untreated bodies of water) or soil, inhalation of cysts, or trauma to the skin or mucous membranes. The amoebae can invade tissues and cause localized or systemic disease depending on the route of entry and host factors.

Risk Factors

• Exposure to contaminated water sources, such as lakes, hot tubs, or tap water.
• Use of contact lenses with improper hygiene or contaminated solutions.
• Skin trauma or wounds that come into contact with contaminated environments.
• Weakened immune system, including conditions like HIV/AIDS, diabetes, or immunosuppressive therapy.
• Prolonged exposure to dust or aerosols containing Acanthamoeba cysts.

Symptoms

• Skin lesions, ulcers, or nodules that are slow to heal.
• Respiratory symptoms, such as cough, chest pain, or shortness of breath.
• Generalized malaise, fever, or weight loss in systemic infections.
• Localized pain or discomfort at the site of infection.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, exposure history, and laboratory testing. Specimens from affected tissues (e.g., skin biopsies, respiratory samples) are examined for Acanthamoeba using microscopy, culture, or molecular methods (e.g., PCR). Imaging studies may be used to assess organ involvement, and histopathology can confirm tissue invasion. Differentiation from other infections is critical to guide treatment.

Treatment Options

Treatment typically includes antimicrobial therapy with agents such as pentamidine, miltefosine, or azithromycin, often in combination. Topical or systemic medications are selected based on the site and severity of infection. In severe cases, surgical intervention (e.g., debridement of skin lesions) may be necessary. Management of underlying risk factors, such as immunosuppression, is also important.

Prognosis and Follow-Up

Prognosis varies depending on the site of infection and host immunity. Early diagnosis and treatment improve outcomes, but severe or disseminated disease can be life-threatening. Follow-up includes monitoring for resolution of symptoms, repeat testing if needed, and addressing any complications. Long-term surveillance may be required for chronic or recurrent infections.

Complications

• Disseminated infection involving multiple organs.
• Chronic skin ulcers or scarring.
• Respiratory failure in severe pulmonary cases.
• Secondary bacterial or fungal infections.
• Neurological impairment if the central nervous system is involved.

Lifestyle & Prevention

• Avoid contact with contaminated water (e.g., untreated lakes, hot tubs) or soil, especially if you have open wounds.
• Practice proper contact lens hygiene, including using sterile solutions and avoiding tap water for cleaning.
• Wear protective clothing or gloves when handling soil or dust in endemic areas.
• Maintain good immune health through balanced nutrition, regular exercise, and management of chronic conditions.
• Seek prompt medical care for skin injuries or respiratory symptoms after potential exposure.

When to Seek Professional Help

Consult a healthcare provider if you experience persistent skin lesions, respiratory symptoms, or systemic signs (e.g., fever, weight loss) after potential exposure to Acanthamoeba. Early evaluation is critical for timely diagnosis and treatment, particularly in immunocompromised individuals.

Tips for Medical Coders

When coding for other acanthamebic disease (B60.19), ensure documentation specifies the site or type of infection (e.g., skin, respiratory) to support the diagnosis. Verify that the condition is not better classified under a more specific code (e.g., keratitis or meningoencephalitis). Include details about exposure history, diagnostic testing, and treatment in the medical record to justify code assignment.